Catalyst Wire Dossier Catalyst Wire Dossier

Roferon

Interferon alfa-2a · Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Roferon, covering 2016-06-23 to 2018-10-29. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies [Phase 2]

See pricing